Clinical Trial Update: The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the efficacy and safety of prostatectomy in men with castration-naive oligometastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Prostatectomy, Oligometastatic Prostate Cancer | Phase 2 | Status: COMPLETED